Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Open Pharma, which works with pharma to drive fast and transparent medical publishing, is encouraging pharmaceutical companies to use their influence more.
Progress has been made towards reducing the 85% of wasted effort in medical research-and the huge amounts of money misspent and harm caused to patients - but there's still a long way to go, say Paul Glasziou and Iain Chalmers.
Study finds that compliance with the European Commission requirement for all trials to post results on to the EUCTR within 12 months of completion has been poor, with half of all trials non-compliant.
If clinicians are expected to change their practice based on their reading of medical journals, they need to know that the evidence in published papers can be verified.
The leaders of Elsevier have now decided that the epoch of journals will soon be over, argues the former editor of the BMJ.
Acceptance rates of articles is higher when first authors come from English-speaking high income countries; and articles from high income countries have higher citation rates.
A series of journalism conferences on obesity received covert funding from Coca-Cola.
Will F1000Research and Wellcome Open Research be replacing journals and editors?
Accessible data are not enough. We need to invest in systems that make the information useful, say Elizabeth Pisani and colleagues.
Prospective cohort study of unsolicited and unwanted academic invitations.
There are better solutions to the “reproducibility crisis” in research
Observational study from 1994 to 2014
Analyzing three decades' worth of PubMed-indexed abstracts, scientists find a notable increase in the frequency of positive words, like "innovative" and "novel", over time.
The data transparency revolution is gathering pace. Last month, the WHO and the Nordic Trial Alliance released important declarations about clinical trial transparency.
An interview with John Ioannidis, co-director of the Meta-Research Innovation Center at Stanford.
New research shows that most exaggeration in health-related science news is already present in the press releases issued by universities.
Definitive solutions won’t come from another million observational papers or small randomized trials by John P A Ioannidis